Cancer Immunotherapy Novel Targets and Immunotherapy are being finely tuned to optimise efficacy and minimise side effects, gradually becoming a standard, perhaps even predominant, method in cancer management.
Experts discuss elusively successful therapies and the rising costs that come with new technologies.
Edited by Tom Cohen |
30 March 2022
Autoimmunity & Immunology
Search by Keyword
Filter by Subject Area
Filter by Content Type
We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.